Illumina公司（納斯達克代碼：ILMN）今日在第43屆J.P.摩根年度醫療大會上宣佈了2024年第四季度和全年未經審計的初步財務結果，以及2025年的預期展望。大會將於2025年1月14日太平洋時間上午9:00（東部時間中午12:00）召開，網絡直播可通過Illumina公司官方網站investor.illumina.com訪問。 Illumina核心業務

• 2024年第四季度收入約爲11億美元，比2023年第四季度增長1％
• 2024年全年收入約爲43.3億美元，比2023年減少2％（按恆定匯率計算）
• 2024年第四季度GAAP營業利潤率約爲16.7%，全年爲34.2%
• 2024年第四季度非GAAP營業利潤率約爲19.7%，全年爲21.3%
• 2024年第四季度GAAP攤薄每股收益約爲0.77-0.79美元，全年爲5.65-5.67美元
• 2024年第四季度非GAAP攤薄每股收益約爲0.91-0.93美元，全年爲4.12-4.14美元
• 2024年運營現金流約爲12.1億美元，自由現金流（運營現金流減去資本支出）約爲10.7億美元
• 預計2025年按恆定匯率計算的收入增長爲低個位數（報告收入在42.8億至44億美元之間），非GAAP營業利潤率約爲23%，非GAAP攤薄每股收益增長約10%

公司計劃於2025年2月6日星期四市場收盤後公佈完整的2024年第四季度和全年財務結果。本新聞稿中的未經審計結果爲初步數據，尚需完成會計和年度審計程序，可能會有所調整。

以上內容來自Benzinga Earnings專欄，原文如下：

Illumina, Inc. (NASDAQ:ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2024 and preliminary outlook for fiscal year 2025 ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). The webcast can be accessed through Illumina's website at investor.illumina.com.

Core Illumina

• Revenue of approximately $1.10 billion for Q4 2024, up 1% from Q4 2023
• Revenue of approximately $4.33 billion for 2024, down 2% from 2023 (and on a constant currency basis)
• GAAP operating margin of approximately 16.7% for Q4 2024 and 34.2% for 2024
• Non-GAAP operating margin of approximately 19.7% for Q4 2024 and 21.3% for 2024
• GAAP diluted EPS of approximately $0.77 - $0.79 for Q4 2024 and $5.65 - $5.67 for 2024
• Non-GAAP diluted EPS of approximately $0.91 - $0.93 for Q4 2024 and $4.12 - $4.14 for 2024
• Cash flow provided by operations of approximately $1.21 billion and free cash flow (cash flow provided by operations less capital expenditures) of approximately $1.07 billion for 2024
• For fiscal year 2025, expect constant currency revenue growth in the low single digits (reported revenue in the range of approximately $4.28 billion to $4.4 billion), non-GAAP operating margin of approximately 23%, and non-GAAP diluted EPS growth of approximately 10%

As previously announced, the company expects to report its full fourth quarter and fiscal year 2024 results following the close of market on Thursday, February 6, 2025. The unaudited results in this press release are preliminary and subject to the completion of accounting and annual audit procedures and are therefore subject to adjustment.